Answers are grounded in this paper and cite their sources.
Observational analysis shows that EGFR inhibitors reduce inflammation in monocytes and macrophages, suggesting a therapeutic avenue for allergies.
These findings suggest that EGFR plays a critical role in mediating Der pII-induced inflammation, and EGFR inhibitors may represent a potential therapeutic approach for controlling HDM-induced allergic inflammation.
No takes yet. Share an insight, caveat, or question.
Chiang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: